BD & LICENSING
Over the years, the pharmaceutical sector has undergone radical changes, indeed, the increasing costs of R&D, the increasingly stringent regulation and the diffusion of generic drugs have pushed pharmaceutical companies to review the business model in order to acquire new competitive advantages and continue to innovate.
Licensing agreements have proved to be a crucial tool for responding to this selective pressure, which is why this type of agreement has been adopted more and more widely among pharmaceutical companies.
The main advantages are:
- innovate by reducing risks
- reduce the "time to market"
- quickly gain a competitive advantage
- penetrare nuovi mercati
- create a network of consolidated partners to draw on for future projects
The partners of D&V FARMA make available, through licensing agreements, an innovative product portfolio for pharmaceutical companies worldwide.
EYE DROPS
EYE DROPS 1
read more
Thanks to the synergistic action of its components, it treats the sign and symptoms linked to ocular surface alterations in diabetic patients: dry eye, recurrent erosions of the corneal epithelium, loss of corneal sensitivity and corneal neuropathy.
Regulatory status: Certified medical device class IIb
Intellectual properties: Patent pending
Evidence: Clinical and preclinical
Contact lens compatibility: Compatible with contact lens
Packaging:
– Multidose
– Multidose preservative free
EYE DROPS 2
read more
It protects the corneal epithelium and promotes the epithelial physiological repairing process, it reduces corneal surface irregularities It creates a protective film to avoid tear evaporation, it promotes ocular surface lubrication and healing and protects the eye from the daily exposure to UV light
Regulatory status: Certified medical device class IIb
Intellectual properties: Paent pending
Evidence: Clinical and preclinical
Contact lens compatibility: Compatible with contact lens
Packaging:
– Multidose
– Multidose preservative free
EYE DROPS 3
read more
It protects the eye from the damages induced by UV and Blu light Anterior segment: Photo-keratitis and photo-keratoconjunctivitis. Posterior segment: AMD
Regulatory status: Certified medical device class IIb and Personal Protective Equipment
Intellectual properties: Patented
Evidence: preclinical
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free
EYE DROPS 4
read more
Antioxidant solution that protects the crystalline lens from photo-oxidative damage, as a result, it preserves the lens’ transparency
Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Evidence: preclinical
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free
EYE DROPS 5
read more
The ophthalmic solution has a protective and lubricant action on corneal epithelium and accelerates the natural repairing process in dry eye. It is a valid support for patients affected by keratoconus, or undergoing corneal crosslinking.
Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free
EYE DROPS 6
read more
Eye drops useful as pre- and post-operative prophylaxis of cataract, glaucoma surgery and intravitreal injections.
Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Evidence: clinical and preclinical
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose
EYE DROPS 7
read more
Hyposmolar gel for dry eye syndrome based on a new chemical entity. Indicated for Dry Eye (mild to severe) and patients with a need for lubrication and reduction of oxidative stress on the ocular surface. Preservative and emulsifier free
Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free
EYE DROPS 8
read more
It is a hypertonic solution for corneal oedema. While most of the competitors take care only of the corneal oedema, our product takes care of two different targets i.e. corneal oedema and it exerts nourishing and antioxidant action and provides photo oxidative protection.
Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free
SURGICAL
Cross-linking equipment
read more
EPI-OFF, EPI-ON:
CXL Continuous and pulsed
User presets
Regulatory status: Certified medical device class IIb
RIBO 1
read more
1.5ml prefilled sterile Syringe
Containing Riboflavin and Dextran.
The formulation further contains a penetration enhancer, and it can be used with every CXL protocol and most UV devices on the market
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Evidence: clinical
RIBO 2
read more
1.5ml prefilled sterile Syringe
Containing Riboflavin and Dextran.
The formulation further contains a penetration enhancer, and it can be used with every CXL protocol and most UV devices on the market
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Evidence: clinical
DYE 1
read more
It is a sterile solution for vitreous tissue staining in vitreoretinal surgery
Advantages:
- – Precise visualization and identification of vitreous
- – Protective and shielding action
- – Increased safety
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
0.5ml prefilled sterile Syringe
DYE 2
read more
It is a sterile solution for epiretinal (ERM) and internal limiting membrane (ILM) staining during vitreoretinal surgery
Advantages:
- – Fast and precise membrane visualization
- – Protective and shielding action
- – Increased safety
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Packaging: 0.5ml prefilled sterile Syringe
DYE 3
read more
Sterile solution for anterior capsule staining during cataract surgery, glaucoma surgery, and corneal transplants
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Packaging: 0.5ml prefilled sterile Syringe
VISCO 1
read more
Visco-surgical devices for intraocular use that create and maintain the anterior chamber space, and protect endothelial cells during the procedures.
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Packaging: 0.8ml prefilled sterile Syringe
DIAGNOSTIC
DIAGNOSTIC 1
read more
Patented eye stain patient friendly alternative to fluorescein
Regulatory status: Certified medical device class IIa
Intellectual properties: Patented
Packaging: Multidose dispenser and single dose viale
Evidence: clinical